Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis

Yi-wen Shi, Jian-Gao Fan

Clin Mol Hepatol. 2023;29(Suppl):S228-S243. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0401

View: 1131 Download: 77

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim

Clin Mol Hepatol. 2021;27(3):402-412. Published online June 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0179

View: 4278 Download: 224 Citations: 25

Original Article

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection

Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh

Clin Mol Hepatol. 2012;18(2):195-202. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.195

View: 8183 Download: 66 Citations: 11

High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn

Clin Mol Hepatol. 2012;18(1):75-83. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.75

View: 6486 Download: 42 Citations: 12

3

Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B

Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.

Clin Mol Hepatol. 2010;16(1):57-65. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.57

View: 4913 Download: 28 Citations: 8

Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients Living in Daejeon and Chungcheong Province in Korea: A comparative study

Jeong Il Kim, M.D, Seok Hyun Kim, M.D., Byung Seok Lee, M.D., Heon Young Lee, M.D., Tae Hee Lee, M.D. Young Woo Kang, M.D. Hyang Ie Lee, M.D. An Na Kim, M.D. Soon Woo Nam, M.D. Byeong Chool Park, M.D. Hee Bok Chae, M.D. Seok Bae Kim, M.D. Il Han Song, M.D. Ji Young Park, M.D. Hong Su Kim, M.D.

Clin Mol Hepatol. 2008;14(4):493-502. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.493

View: 4133 Download: 20 Citations: 9

1 |

Viewed By 4154	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3564	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 2827	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2782	Recent updates on the management of autoimmune hepatitis
Viewed By 2705	Identification of high-risk subjects in nonalcoholic fatty liver disease

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 42	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search